Zomedica Past Earnings Performance
Past criteria checks 0/6
Zomedica's earnings have been declining at an average annual rate of -2.3%, while the Medical Equipment industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 76.7% per year.
Key information
-2.3%
Earnings growth rate
52.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 76.7% |
| Return on equity | -14.4% |
| Net Margin | -137.1% |
| Next Earnings Update | 09 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Zomedica makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 25 | -35 | 43 | 6 |
| 30 Sep 23 | 24 | -15 | 39 | 3 |
| 30 Jun 23 | 22 | -19 | 38 | 4 |
| 31 Mar 23 | 21 | -19 | 37 | 3 |
| 31 Dec 22 | 19 | -17 | 33 | 3 |
| 30 Sep 22 | 17 | -17 | 32 | 3 |
| 30 Jun 22 | 12 | -19 | 30 | 2 |
| 31 Mar 22 | 8 | -18 | 26 | 2 |
| 31 Dec 21 | 4 | -50 | 23 | 2 |
| 30 Sep 21 | 0 | -51 | 18 | 2 |
| 30 Jun 21 | 0 | -50 | 14 | 4 |
| 31 Mar 21 | 0 | -51 | 11 | 8 |
| 31 Dec 20 | 0 | -17 | 9 | 8 |
| 30 Sep 20 | 0 | -16 | 7 | 8 |
| 30 Jun 20 | 0 | -13 | 7 | 6 |
| 31 Mar 20 | 0 | -11 | 6 | 3 |
| 31 Dec 19 | 0 | -20 | 9 | 10 |
| 30 Sep 19 | 0 | -25 | 9 | 16 |
| 30 Jun 19 | 0 | -24 | 8 | 16 |
| 31 Mar 19 | 0 | -26 | 9 | 17 |
| 31 Dec 18 | 0 | -17 | 6 | 10 |
| 30 Sep 18 | 0 | -11 | 6 | 5 |
| 30 Jun 18 | 0 | -11 | 6 | 5 |
| 31 Mar 18 | 0 | -8 | 6 | 3 |
| 31 Dec 17 | 0 | -8 | 5 | 3 |
| 30 Sep 17 | 0 | -8 | 6 | 2 |
| 30 Jun 17 | 0 | -7 | 5 | 2 |
| 31 Mar 17 | 0 | -7 | 5 | 2 |
| 31 Dec 16 | 0 | -6 | 4 | 1 |
| 30 Sep 16 | 0 | -4 | 3 | 1 |
Quality Earnings: ZOM is currently unprofitable.
Growing Profit Margin: ZOM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZOM is unprofitable, and losses have increased over the past 5 years at a rate of 2.3% per year.
Accelerating Growth: Unable to compare ZOM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZOM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).
Return on Equity
High ROE: ZOM has a negative Return on Equity (-14.39%), as it is currently unprofitable.